Found 0 matching trials
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies EARLY_PHASE1 This study aims to improve the treatment of blood cancer by using exercise ...
Show More Location
The University of Arizona
Learn More & Join Trial
Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas PHASE1 Progress in the treatment of children with leukemia and lymphoma results in...
Show More Location
National University Hospital
Learn More & Join Trial
Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies PHASE1 This Phase 1, first-in-human (FIH), open-label study is designed to assess ...
Show More Location
Greenslopes Private Hospital/Gallipoli Medical Research Foundation
Learn More & Join Trial
Therapy for Children With Advanced Stage Neuroblastoma PHASE2 Neuroblastoma is the most common extracranial solid tumor in childhood, wit...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma PHASE1 Activation of the RIG-I innate immune pathway and increased expression of t...
Show More Status
Active Not Recruiting
Location
University of Colorado Hospital
Learn More & Join Trial
A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study PHASE1 This is a Phase I, open-label study to explore the safety profile and to fi...
Show More Location
Chang Gung Memorial Hospital, Linkou
Learn More & Join Trial
MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients PHASE2 A phase II trial of CD3/CD19 depleted, IL-15 activated, donor natural kille...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int PHASE1 This is a Phase I trial to determine the maximum tolerated dose/maximum fea...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS PHASE1 This is an open-label study of the safety, biodynamics, and anti-cancer act...
Show More Status
Active Not Recruiting
Location
UCLA Medical Center
Learn More & Join Trial